FDA Inspection
Avista Pharma Solutions, Inc.Avista Pharma Solutions, Inc. – FDA Inspection, Dec 18, 2019
Record Details
This FDA Inspection record concerns Avista Pharma Solutions, Inc., with an inspection on December 18, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 18, 2019
- Product Type
- Drugs
View Company Profile
ID · 43a50e53-b23a-4132-b1c6-e57509860e23
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1113974
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Avista Pharma Solutions, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2026 | Not classified | New England District Office | Human Cellular, Tissue, and Gene Therapies |
| July 25, 2025 | VAI | New England District Office | Drug Quality Assurance |
| September 5, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Avista Pharma Solutions, Inc.
- FDA Inspection 1332618 - 2026-08-14
- FDA Inspection 1278383 - 2025-07-25
- FDA Inspection 1067530 - 2018-09-05
- FDA Inspection 988732 - 2016-06-15
- FDA Inspection 850250 - 2013-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.